Changes in circulating levels of calcitonin gene-related peptide and nitric oxide metabolites in septic patients during direct hemoperfusion with polymyxin B-immobilized fiber

Blood Purif. 2003;21(3):237-43. doi: 10.1159/000070696.

Abstract

Background/aims: This study evaluated the mechanism of hemodynamic improvement in polymyxin B-immobilized fiber (PMX) treatment.

Methods: Fifteen septic patients with endotoxemia and/or gram negative infection were treated with PMX. Plasma concentrations of calcitonin gene-related peptide (CGRP) and nitric oxide metabolites were measured.

Results: CGRP and nitric oxide metabolites before treatment were significantly higher than in healthy controls. CGRP had a significantly inverse correlation with diastolic blood pressure and a positive correlation with the Septic Severity Score and the number of failed organs. Systolic and diastolic blood pressure and systemic vascular resistance index increased significantly both immediately after and 24 h after PMX treatment. CGRP decreased significantly 24 h after the treatment. In contrast, there were no significant changes in nitric oxide metabolites.

Conclusion: PMX treatment improved hemodynamic parameters in septic patients, and CGRP increased with increasing severity of sepsis. We conclude that a decrease in CGRP levels may be related to hemodynamic improvement resulting from PMX treatments.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Blood Pressure
  • Calcitonin Gene-Related Peptide / blood*
  • Female
  • Hemodynamics
  • Hemoperfusion / methods*
  • Humans
  • Male
  • Middle Aged
  • Multiple Organ Failure
  • Nitric Oxide / blood*
  • Nitric Oxide / metabolism
  • Polymyxin B*
  • Sepsis / blood
  • Sepsis / therapy*
  • Severity of Illness Index
  • Vascular Resistance
  • Vasoconstrictor Agents / therapeutic use
  • Vasodilation

Substances

  • Vasoconstrictor Agents
  • Nitric Oxide
  • Polymyxin B
  • Calcitonin Gene-Related Peptide